Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,075 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.
Torres A, Zhong N, Pachl J, Timsit JF, Kollef M, Chen Z, Song J, Taylor D, Laud PJ, Stone GG, Chow JW. Torres A, et al. Among authors: taylor d. Lancet Infect Dis. 2018 Mar;18(3):285-295. doi: 10.1016/S1473-3099(17)30747-8. Epub 2017 Dec 16. Lancet Infect Dis. 2018. PMID: 29254862 Free article. Clinical Trial.
Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End Points.
Torres A, Rank D, Melnick D, Rekeda L, Chen X, Riccobene T, Critchley IA, Lakkis HD, Taylor D, Talley AK. Torres A, et al. Among authors: taylor d. Open Forum Infect Dis. 2019 Apr 25;6(4):ofz149. doi: 10.1093/ofid/ofz149. eCollection 2019 Apr. Open Forum Infect Dis. 2019. PMID: 31041348 Free PMC article.
In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.
Stone GG, Bradford PA, Tawadrous M, Taylor D, Cadatal MJ, Chen Z, Chow JW. Stone GG, et al. Among authors: taylor d. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02356-19. doi: 10.1128/AAC.02356-19. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32071051 Free PMC article. Clinical Trial.
Modelled impact of virtual fractional flow reserve in patients undergoing coronary angiography (VIRTU-4).
Ghobrial M, Haley H, Gosling R, Taylor DJ, Richardson J, Morgan K, Barmby D, Iqbal J, Krishnamurthy A, Singh R, Conway D, Hall I, Adam Z, Wheeldon N, Grech ED, Storey RF, Rothman A, Payne G, Tahir MN, Smith S, Cooke J, Hunter S, Cartwright N, Sadeque S, Briffa NP, Al-Mohammad A, O'Toole L, Rogers D, Lawford PV, Hose DR, Gunn J, Morris PD. Ghobrial M, et al. Among authors: taylor dj. Heart. 2024 May 16:heartjnl-2024-324039. doi: 10.1136/heartjnl-2024-324039. Online ahead of print. Heart. 2024. PMID: 38754969 Free article.
Implementation of the World Health Organization's QualityRights initiative in Ghana: an overview.
Osei AO, Amissah C, Hanu SC, Tawiah PE, Brobbey KA, Arthur YA, Ansong J, Ohene SA, Gyimah L, Kofie H, Taylor D, Yaro PB, Funk M, Drew N, Moro MF, Carta MG, Baingana FK, Kpesese VK, Orrell M, Cole C; WHO QualityRights Ghana Team. Osei AO, et al. Among authors: taylor d. BJPsych Open. 2024 May 13;10(3):e111. doi: 10.1192/bjo.2024.11. BJPsych Open. 2024. PMID: 38736413 Free PMC article.
9,075 results